Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000

Journal of Clinical Pathology - Tập 59 Số 1 - Trang 48-55 - 2006
Thomas Mitterlechner1, Michael Fiegl2, H. Mühlböck3, Willi Oberaigner3, Stefan Dirnhofer4, Alexandar Tzankov5
1The Institute of Pathology, Medical University of Innsbruck, Muellerstrasse 44, 6020 Innsbruck, Austria
2The Natters Hospital, 6161 Natters, Austria
3The Cancer Registry of Tyrol, Department of Clinical Epidemiology of the Tyrolean State Hospital, 6020 Innsbruck, Austria
4The University of Basel, 4031 Basel, Switzerland
5Innsbruck Medical University, Muellerstrasse 44, 6020 Innsbruck, Austria

Tóm tắt

Aims:To analyse the entity specific incidence and disease specific survival (DSS) of non-Hodgkin lymphomas (NHLs) in Tyrol/Austria, 1991–2000.

Methods:Data from 1307 NHLs (excluding primary cutaneous lymphomas and monoclonal gammopathies of undetermined significance) were obtained. Current status was available for all patients. Except for 29 cases of small lymphocytic (CLL/SLL), lymphoblastic leukaemia (ALL), and myeloma (MM), which were diagnosed cytologically, diagnoses were reclassified on paraffin wax embedded archival material according to new World Health Organisation criteria. Sex specific age adjusted standardised incidence rates were computed using Segi’s population weighting. Annual incidence changes were calculated by weighted least square regression analysis. Survival was estimated by the Kaplan–Meier method and compared by log rank test.

Results:NHL more frequently affected men (male/female ratio, 1.52). Mean age of occurrence was 61 and 66 years for men and women, respectively. The incidence rate of 14.3 remained constant. There was a significant increase in diffuse large B cell lymphoma (DLBCL) and decrease in CLL/SLL in men, and a decrease in MM in women. Overall DSS was 64% during the mean follow up (43 months). Age, T-NHL, λ light chain restriction in MM, and male sex in CLL/SLL were associated with poor prognosis. In B-NHL, DSS decreased in the following order: hairy cell leukaemia, marginal zone lymphoma, follicular lymphoma, Burkitt lymphoma, ALL, DLBCL, CLL, MM, and mantle cell lymphoma.

Conclusions:The incidence of NHL in Tyrol has changed in the past decade, with a significant increase in DLBCL, decrease in CLL/SLL in men, and decrease in MM in women.

Từ khóa


Tài liệu tham khảo

Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.

10.1016/S0959-8049(98)00401-8

2001, Haematologica, 86, 58

10.1093/jnci/93.11.824

1998, Cancer Epidemiol Biomarkers Prev, 7, 621

1994, Br J Cancer, 70, 713, 10.1038/bjc.1994.380

1992, Cancer Res, 52, 5432s

10.1093/jnci/92.15.1240

10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R

10.1016/S0145-2126(97)00062-3

1999, Semin Oncol, 26, 21

1994, Cancer Res, 54, 2386

2003, Environ Health Perspect, 111, 1704, 10.1289/ehp.6270

10.1136/oem.52.6.374

10.1097/00001648-199709000-00013

2002, J Occup Environ Med, 44, 469, 10.1097/00043764-200205000-00015

10.1002/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X

10.1182/blood-2002-10-3230

10.1002/(SICI)1097-0215(19991112)83:4<481::AID-IJC8>3.0.CO;2-5

1996, Blood, 87, 4296, 10.1182/blood.V87.10.4296.bloodjournal87104296

10.1016/0140-6736(93)91409-F

10.1097/00062752-200201000-00009

1998, Am J Epidemiol, 148, 833, 10.1093/oxfordjournals.aje.a009708

10.1023/A:1008897203337

10.1093/jnci/91.20.1751

1992, Am J Public Health, 82, 990, 10.2105/AJPH.82.7.990

10.1023/A:1008926027805

10.1002/ijc.11356

1992, Cancer Res, 52, 5465s

1992, Semin Diagn Pathol, 9, 297

10.1016/S0959-8049(99)00025-8

10.1016/S1568-9972(03)00006-5

10.1016/0959-8049(96)00210-9

10.1111/j.1365-2567.2004.02006.x

10.1080/1042819021000038010

1994, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361

10.1136/jcp.56.3.193

10.1136/jcp.55.12.892

Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai, Japan: Tohoku University of Medicine, 1960.

10.1046/j.1365-2141.2002.03750.x

1992, Cancer Res, 52, 5453s

2001, Cancer Epidemiol Biomarkers Prev, 10, 361

10.1053/tm.20000.7395

1997, Ann Intern Med, 127, 365, 10.7326/0003-4819-127-5-199709010-00004

10.1046/j.1537-2995.1997.371098016450.x

1992, Int J Cancer, 50, 163, 10.1002/ijc.2910500132

1990, Int J Cancer, 46, 755, 10.1002/ijc.2910460435

10.1016/S0753-3322(02)00194-4

1996, Deutsches Ärzteblatt, 93, A2845

2003, Can J Gastroenterol, 17, 49B, 10.1155/2003/704035

1993, N Engl J Med, 29, 987

1999, Semin Oncol, 26, 12

10.1634/theoncologist.6-3-247

1976, Blood, 48, 41, 10.1182/blood.V48.1.41.41

10.1023/A:1008418727472

1999, Semin Hematol, 36, 155

10.1055/s-2002-35017

10.1182/blood-2002-01-0263

10.1097/00000478-199810000-00003

1998, Am J Pathol, 153, 1707, 10.1016/S0002-9440(10)65685-4

10.1097/01.pap.0000138144.11635.f8

10.1093/jnci/88.10.675

10.1093/annonc/mdh274

10.1111/j.1365-2141.2004.04898.x

10.1006/jmcc.2002.2110

Thông tin
Thông tin xuất bản

Journal of Clinical Pathology

Tập 59 Số 1

48-55

Thông tin tác giả